CYP3A activity in severe liver cirrhosis correlates with Child-Pugh and model for end-stage liver disease (MELD) scores.
about
Molecular changes in hepatic metabolism and transport in cirrhosis and their functional importanceSignificant change of cytochrome P450s activities in patients with hepatocellular carcinomaExpression of P450 and nuclear receptors in normal and end-stage Chinese livers.Arrhythmia risk in liver cirrhosis.Changes in cytochrome P450s-mediated drug clearance in patients with hepatocellular carcinoma in vitro and in vivo: a bottom-up approach.Review article: safety and tolerability of direct-acting anti-viral agents in the new era of hepatitis C therapy.CYP3A activity: towards dose adaptation to the individual.Pharmacokinetic considerations and recommendations in palliative care, with focus on morphine, midazolam and haloperidol.Drug metabolism and liver disease: a drug-gene-environment interaction.A Prediction Model of Drug Exposure in Cirrhotic Patients According to Child-Pugh Classification.Benzodiazepines and risk for hepatic encephalopathy in patients with cirrhosis and ascites.
P2860
Q26769609-2856671D-5647-4371-8B94-9DF4AA9819E4Q28468624-3BF9ECAF-BC4F-4297-80FA-DBDCEAD30E7AQ33887136-9D4344B3-A2ED-4F08-981D-EF99A30937ADQ35308671-8A0A1D4E-1C2D-4F4B-92FB-F01CD4D6A88EQ37317619-F6DF5F90-3164-4884-90D4-589F6AE2182CQ38703524-18610D68-7413-4A95-AE20-C52E7B1EAB99Q38763583-45866D6D-A4B9-45AE-B28F-0DF03E957FB0Q38809021-59F6B36D-7FE1-4DA7-944F-1B58D96EE405Q39037269-D3BA247F-47EA-452F-ABE0-F0EE0158614DQ40839485-6285AE16-4D3C-4BF9-A343-4A7AFDE3174DQ54960926-382087D8-70C9-4489-84F5-71AC07D3B6FF
P2860
CYP3A activity in severe liver cirrhosis correlates with Child-Pugh and model for end-stage liver disease (MELD) scores.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CYP3A activity in severe liver ...... e liver disease (MELD) scores.
@en
CYP3A activity in severe liver ...... el for end-stage liver disease
@nl
type
label
CYP3A activity in severe liver ...... e liver disease (MELD) scores.
@en
CYP3A activity in severe liver ...... el for end-stage liver disease
@nl
prefLabel
CYP3A activity in severe liver ...... e liver disease (MELD) scores.
@en
CYP3A activity in severe liver ...... el for end-stage liver disease
@nl
P2093
P2860
P356
P1476
CYP3A activity in severe liver ...... e liver disease (MELD) scores.
@en
P2093
Albader Albarmawi
Annika Gauss
David Czock
Justo Lorenzo Bermejo
Peter Sauer
Robert Ehehalt
Tom M Ganten
P2860
P304
P356
10.1111/BCP.12182
P407
P577
2014-01-01T00:00:00Z